France · Series B startup

Who invested in Meccellis Biotech

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$8.3Mraised across 1 round since 2022, from 1 source

Latest round
Series B, $8.3MNov 2022
Investors
1
See who backed them

The rounds

  1. Nov 2022
    Series B$8.3M

    Source recorded

Founders and team

From Meccellis Biotech's own website: 8 on the team.

  • Anthony PérèsCEO – R&D Director
  • Stéphane MilotCFO
  • Aurélie LammelinVice general Director
  • Claire CisterniClinical Affairs Manager
  • Emilie AlazardIndustrial Manager
  • Erwan PérèsSales Manager
  • Guillaume HofmanskiGeneral Director
  • Sophie RenéQuality and Regulatory Affairs Manager

Everyone who backed them

BpifranceGovernment1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Meccellis Biotech

Who invested in Meccellis Biotech?

Meccellis Biotech's investors include Bpifrance.

How much has Meccellis Biotech raised?

Meccellis Biotech has raised $8.3M across 1 round since 2022.

When did Meccellis Biotech last raise?

Meccellis Biotech's most recent round was a Series B of $8.3M in Nov 2022.

What was Meccellis Biotech's biggest round?

Its most recent round, $8.3M in Nov 2022, is also its largest on record.

Who backed Meccellis Biotech first?

Meccellis Biotech's first round on record, in Nov 2022, was backed by Bpifrance.

What stage is Meccellis Biotech at?

Meccellis Biotech's latest named round is a Series B, in Nov 2022.

Where is Meccellis Biotech based?

Meccellis Biotech is based in France.

Companies like Meccellis Biotech

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.